| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |